Announcements Trials
Browse Landscape

Phase

Phase 2 51Phase 1 49Phase 1/2 37Phase NA 16Phase 3 15Phase 4 2Phase 2/3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 13Breast 12Tumor-Agnostic 9Genitourinary 9Head & Neck 5Dermatologic 5CNS 4Thoracic 3Sarcoma 2Gynecologic 1

Conditions

Gastrointestinal Stromal Tumors 10Bone Neoplasms 9Sarcoma 8Neoplasms 3Multiple Myeloma 3Sarcoma, Kaposi 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Osteosarcoma 2Neoplasm Metastasis 2Lymphoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Anemia 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Renal Insufficiency 1Recurrence 1Rectal Neoplasms 1Psoriasis 1Prostatic Neoplasms 1Progressive Gastrointestinal Stromal Tumor 1Piebaldism 1Pancreatic Neoplasms 1Pain, Intractable 1

Interventions

Ibandronic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm Metastasis × Sarcoma × Clear all
NCT02564107 2016-11-02

A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Hoffmann-La Roche

Phase 4 Completed
48 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

NCT02553707 2015-09-17

A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer

Hoffmann-La Roche

Phase 4 Completed
182 enrolled
Sarcoma

Bone Neoplasms, Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡